Bone Marrow Infiltration Is a Distinctive Risk Factor for Rituximab Infusion-Related Reactions in CD20-Positive B-Cell Non-Hodgkin Lymphoma.

Shinya OhataKei TakenakaDaisuke SugiyamaTakeshi Sugimoto

Published in: Advances in hematology (2022)

Bone marrow infiltration of B-NHL cells is a risk factor for grade 2 or higher IRRs at the first rituximab induction therapy without glucocorticoid premedication.

Keyphrases

bone marrow
diffuse large b cell lymphoma
mesenchymal stem cells
induced apoptosis
chronic lymphocytic leukemia
cell cycle arrest
hodgkin lymphoma
low dose
endoplasmic reticulum stress
stem cells
signaling pathway
pi k akt